Publication | Closed Access
An exploratory study of body composition as a predictor of dose-limiting toxicity in metastatic pancreatic cancer treated with gemcitabine plus nab-paclitaxel
20
Citations
19
References
2021
Year
OncologyBody CompositionPancreatic CancerGastrointestinal OncologyPharmacologyPharmacotherapyMetastatic Pancreatic CancerCancer TreatmentDose-limiting ToxicityMedicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1